Statements: GSK Advance Company Ltd

Canonical ID: NK-QfFkwcpTeaFHBpwC4e2GeA · Entity type: Company (reference)

PropertyValueLangSource datasetSource IDFirst seen
Organization:ide9343fc199762a32a9069e8aa61b2e1619813d33enggb_coh_disqualifiedgb-coh-swwsm-n6bfso9gnhc1ioyxrenbq
Organization:id94a357858224290b67a86ed8f0d153eb3c83fbb5enggb_fcdo_sanctionsgb-fcdo-sud0010
LegalEntity:ide10d184d72ac8f85f9f31011542239b3f5b431acca_dfatd_sema_sanctionsca-sema-5e673fd66cb1125630cca1bd07abd7d4d227338f
Organization:idd3e12e942d40ccdcf5500199d3af7a90cc44dd2eus_trade_cslofac-45288
Organization:id67557f2fc52649fe04429e8d1eb625afd352f493frafr_tresor_gels_avoirfr-ga-7112
Organization:id5ae5a4fc57b9d91955a8a7396c5a838807ca3ffceu_fsfeu-fsf-eu-11097-27
Organization:id2c2c42b4238ac5d9141d33934c648ced68d6b22cframc_fund_freezesmc-freezes-fce8cd441c161d7708ba9c08a326ae53f8e2358e
LegalEntity:idf4daa6aac0861970703bbdb25a2a7a11d7a62371engus_sam_exclusionsusgsa-s4mrvqghp
LegalEntity:id40be8bfdb51199a1dc672c07b6f32c54306ee96cengus_sam_exclusionsusgsa-s4mrvqhwx
LegalEntity:ide1a0390be4a827ddbd0da935ee64a98168d73b4cengus_sam_exclusionsusgsa-s4mrvqp60
LegalEntity:idcf431519c1ce66d7313b16e317d415a71b8befcfengus_sam_exclusionsusgsa-s4mrvqqh0
Company:id6748437721ea5ff49517461a1e585efe7f036d8fpermidpermid-5086676964
Company:id1e1bf5c2101f03b8c9d6ea3bae4759863ba744fdext_us_ofac_press_releasesNK-QfFkwcpTeaFHBpwC4e2GeA
LegalEntity:idb06cd4661a2871ea87eef636c3c1296703074f60ch_seco_sanctionsch-seco-73715
LegalEntity:idd052a7ed8c01f0cfddadd730403fc3a06542ee5aenggb_hmt_sanctionsgb-hmt-16008
LegalEntity:idb4319c4fa2484cd767956d51ea9bd32b9480b586enggb_hmt_sanctionsgb-hmt-16008
LegalEntity:id6dce1fab483a864d6ca5e741cbfb22b8800b88feenggb_hmt_sanctionsgb-hmt-16008
Organization:idffeab28a2b6afb999be4c9d33210b0d52656b022be_fod_sanctionseu-fsf-eu-11097-27
Organization:id69be1749378f07e84da8204cf719652ee53c72c4engus_ofac_sdnofac-45288
  • Previous
  • 1 - 19 of 19
  • Next